INDP
Indaptus Therapeutics, Inc.
Company overview
- Market capitalization
- $438.37M
- Employees
- 5
- Latest publication
- 2026-09-29
About Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,470USD | 0USD | 0USD |
| Research Development | 491,134USD | 2,845,282USD | 1,517,723USD | 2,167,114USD | 2,810,840USD | 2,479,945USD | 1,466,037USD | 1,713,973USD |
| Selling General Administrative | 1,668,454USD | 5,310,422USD | 1,130,764USD | 2,289,649USD | 1,761,719USD | 1,691,625USD | 1,676,020USD | 2,394,912USD |
| Total Operating Expenses | 2,159,588USD | 8,155,704USD | 2,648,487USD | 4,456,763USD | 4,572,559USD | 4,171,570USD | 3,142,057USD | 4,108,885USD |
| Operating Income | -2,159,588USD | -8,155,704USD | -2,648,487USD | -4,456,763USD | -4,572,559USD | -4,171,570USD | -3,142,057USD | -4,108,885USD |
| Income Before Tax | -2,541,070USD | -8,112,450USD | -2,975,117USD | -5,228,919USD | -4,532,430USD | -4,131,047USD | -3,069,036USD | -4,015,267USD |
| Net Income | -2,541,070USD | -8,112,450USD | -2,975,117USD | -5,228,919USD | -4,532,430USD | -4,131,047USD | -3,069,036USD | -4,015,267USD |
| Net Income From Continuing Ops | -2,541,070USD | -8,112,450USD | -2,975,117USD | -5,228,919USD | -4,532,430USD | -4,131,047USD | -3,069,036USD | -4,015,267USD |
| Ebitda | -2,159,588USD | -8,155,704USD | -2,975,117USD | -5,228,916USD | -4,572,559USD | -4,131,050USD | -3,142,057USD | -4,108,885USD |
| Total Other Income Expense Net | -381,482USD | 43,254USD | -326,630USD | -772,156USD | 40,129USD | 40,523USD | 73,021USD | 93,618USD |
| Reconciled Depreciation | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | — | — | — | — | — | -735USD | — | — |
| Gross Profit | — | — | — | — | — | 735USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | 735USD | — | 25,462USD |
| Income Tax Expense | — | — | — | — | — | -4USD | — | — |
| Ebit | — | — | — | — | — | -4,171,570USD | — | — |
| Depreciation And Amortization | — | — | — | — | — | -735USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Research Development | 9,340,959USD | 7,251,097USD | 7,621,707USD | 6,324,657USD | 2,523,153USD | 2,655,017USD | 26,659,000USD | 35,402,000USD |
| Selling General Administrative | 10,492,554USD | 8,114,654USD | 8,756,767USD | 8,586,249USD | 5,205,955USD | 944,248USD | 542,556USD | — |
| Total Operating Expenses | 19,833,513USD | 15,365,751USD | 16,378,474USD | 14,910,906USD | 7,729,108USD | 3,599,265USD | 34,092,000USD | 42,469,000USD |
| Operating Income | -19,833,513USD | -15,365,751USD | -16,378,474USD | -14,910,906USD | -7,729,108USD | -3,599,265USD | -34,946,000USD | -43,328,000USD |
| Income Before Tax | -20,848,916USD | -15,022,027USD | -15,423,471USD | -14,322,798USD | -7,711,386USD | -3,584,151USD | -46,961,000USD | -43,440,000USD |
| Net Income | -20,848,916USD | -15,022,027USD | -15,423,471USD | -14,322,798USD | -7,711,386USD | -3,584,151USD | -47,599,000USD | -43,543,000USD |
| Net Income From Continuing Ops | -20,848,916USD | -15,022,027USD | -15,076,468USD | -14,322,798USD | -7,711,386USD | -3,584,151USD | — | — |
| Ebitda | -19,833,513USD | -15,365,016USD | -16,377,190USD | -14,909,125USD | -7,727,705USD | -3,598,413USD | -46,092,000USD | -42,558,000USD |
| Reconciled Depreciation | 0USD | 735USD | 1,285USD | 1,781USD | 1,403USD | 852USD | — | — |
| Total Other Income Expense Net | -1,015,403USD | 343,724USD | 955,003USD | 588,108USD | 17,722USD | 15,114USD | -12,015,000USD | -112,000USD |
| Cost Of Revenue | — | 735USD | 1,284USD | 1,781USD | 1,403USD | 852USD | 854,000USD | 859,000USD |
| Gross Profit | — | -735USD | -1,284USD | -1,781USD | -1,403USD | -852USD | -854,000USD | -859,000USD |
| Selling And Marketing Expenses | — | 101,847USD | 100,742USD | — | — | 27,554USD | 7,432,457USD | — |
| Ebit | — | -15,365,751USD | -16,378,474USD | -14,910,906USD | -7,729,108USD | -3,599,265USD | -46,946,000USD | -43,417,000USD |
| Depreciation And Amortization | — | 735USD | 1,284USD | 1,781USD | 1,403USD | 852USD | 854,000USD | 859,000USD |
| Income Tax Expense | — | — | -16,379,758USD | -588,108USD | -17,722USD | -15,114USD | 638,000USD | 103,000USD |
| Interest Income | — | — | — | 588,108USD | 17,722USD | 15,114USD | — | — |
| Interest Expense | — | — | — | 588,108USD | 17,722USD | 15,114USD | 15,000USD | 23,000USD |
| Net Interest Income | — | — | — | 588,108USD | 17,722USD | 15,114USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -14,322,798USD | -7,711,386USD | -3,584,151USD | -2,565,207USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | 7,067,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,987,956USD | 2,180,856USD | 9,310,168USD | 6,840,052USD | 6,839,207USD | 5,411,622USD | 7,338,756USD | 8,239,806USD |
| Cash And Equivalents | 7,553,820USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 11,553,820USD | 1,497,635USD | 8,507,628USD | 5,825,639USD | 6,157,701USD | 3,891,021USD | 5,786,753USD | 7,380,686USD |
| Short Term Investments | 4,000,000USD | — | — | — | — | — | — | — |
| Other Current Assets | 27,777USD | 683,221USD | 802,540USD | 613,354USD | 255,357USD | 1,069,910USD | 831,577USD | 248,737USD |
| Total Liabilities | 615,426USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 11,372,530USD | 1,247,857USD | 3,151,593USD | 4,605,727USD | -1,673,356USD | 2,799,731USD | 3,944,875USD | 6,003,326USD |
| Total Equity Including Noncontrolling Interest | 11,372,530USD | — | — | — | — | — | — | — |
| Accounts Payable | 508,877USD | 557,367USD | 544,057USD | 707,420USD | 618,515USD | 1,311,095USD | 870,229USD | 555,949USD |
| Common Stock | 1,332,424USD | 1,132,424USD | 21,674USD | 16,420USD | 6,050USD | 160,344USD | 120,139USD | 101,969USD |
| Retained Earnings | -85,624,032USD | -83,829,169USD | -81,288,099USD | -73,175,649USD | -70,200,531USD | -64,971,613USD | -60,439,183USD | -56,308,136USD |
| Total Liab | — | 932,999USD | 6,158,575USD | 2,234,325USD | 8,512,563USD | 2,611,891USD | 3,393,881USD | 2,236,480USD |
| Other Current Liab | — | 375,632USD | 5,614,518USD | 1,518,219USD | 1,357,172USD | 1,241,284USD | 2,439,488USD | 1,572,542USD |
| Capital Stock | — | 1,132,424USD | 31,674USD | 16,420USD | 6,050USD | 160,344USD | 120,139USD | 101,969USD |
| Cash | — | 1,497,635USD | 8,507,628USD | 5,825,639USD | 6,157,701USD | 3,891,021USD | 5,786,753USD | 7,380,686USD |
| Total Current Assets | — | 2,180,856USD | 9,310,168USD | 6,438,993USD | 6,413,058USD | 4,960,931USD | 6,618,330USD | 7,629,423USD |
| Total Current Liabilities | — | 932,999USD | 6,158,575USD | 2,234,325USD | 8,512,563USD | 2,611,891USD | 3,393,881USD | 2,232,473USD |
| Net Debt | — | -1,497,635USD | -8,507,628USD | -5,816,953USD | 379,175USD | -3,831,509USD | -5,702,589USD | -7,272,697USD |
| Common Stock Shares Outstanding | — | 2,167,324shares | 2,167,324shares | 5,761,517shares | 5,761,517shares | 9,355,710shares | 9,355,710shares | 9,510,447shares |
| Non Current Assets Total | — | 0USD | 0USD | 401,059USD | 426,149USD | 450,691USD | 720,426USD | 610,383USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 4,007USD |
| Net Working Capital | — | 1,247,857USD | 3,151,593USD | 4,204,668USD | -2,099,505USD | 2,349,040USD | 3,224,449USD | 5,396,950USD |
| Unclassified Equity | — | 82,812,178USD | 84,386,344USD | 77,748,536USD | 68,515,075USD | 67,450,656USD | 64,143,780USD | 62,107,524USD |
| Property Plant Equipment Net | — | — | 0USD | 8,487USD | 33,577USD | 58,119USD | 82,175USD | 105,655USD |
| Property Plant Equipment Gross | — | — | 0USD | 8,487USD | 33,577USD | 58,119USD | 82,175USD | 105,655USD |
| Short Term Debt | — | — | — | 8,686USD | 6,536,876USD | 59,512USD | 84,164USD | 103,982USD |
| Short Long Term Debt Total | — | — | — | 8,686USD | 6,536,876USD | 59,512USD | 84,164USD | 107,989USD |
| Non Currrent Assets Other | — | — | — | 392,572USD | 392,572USD | 392,572USD | 638,251USD | 504,728USD |
| Short Long Term Debt | — | — | — | — | 6,502,503USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -6,502,503USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,310,168USD | 7,338,756USD | 14,923,878USD | 28,063,806USD | 40,576,583USD | 1,777,793USD | 21,280,000USD | 61,510,000USD |
| Other Current Assets | 802,540USD | 831,577USD | 633,156USD | 811,433USD | 1,233,997USD | 94,500USD | 197,000USD | 955,000USD |
| Total Liab | 6,158,575USD | 3,393,881USD | 2,847,380USD | 3,433,341USD | 4,677,003USD | 2,015,494USD | 9,745,000USD | 7,965,000USD |
| Total Stockholder Equity | 3,151,593USD | 3,944,875USD | 12,076,498USD | 24,630,465USD | 35,899,580USD | -237,701USD | 11,535,000USD | 53,545,000USD |
| Other Current Liab | 5,614,518USD | 2,439,488USD | 1,826,323USD | 1,845,602USD | 1,869,870USD | 1,859,537USD | 4,291,000USD | 4,807,000USD |
| Common Stock | 21,674USD | 120,139USD | 84,011USD | 84,011USD | 82,586USD | 19,447USD | 727,000USD | 727,000USD |
| Capital Stock | 31,674USD | 120,139USD | 84,011USD | 84,011USD | 82,586USD | 27,806USD | — | — |
| Retained Earnings | -81,288,099USD | -60,439,183USD | -45,417,156USD | -29,993,685USD | -15,670,887USD | -7,959,501USD | -189,423,000USD | -141,824,000USD |
| Cash | 8,507,628USD | 5,786,753USD | 13,362,053USD | 9,626,800USD | 39,132,165USD | 1,637,499USD | 9,292,000USD | 39,246,000USD |
| Cash And Short Term Investments | 8,507,628USD | 5,786,753USD | 13,362,053USD | 26,432,809USD | 39,132,165USD | 1,637,499USD | 10,062,000USD | 40,579,000USD |
| Total Current Assets | 9,310,168USD | 6,618,330USD | 13,995,209USD | 27,244,242USD | 40,387,218USD | 1,731,999USD | 13,745,000USD | 43,565,000USD |
| Total Current Liabilities | 6,158,575USD | 3,393,881USD | 2,774,032USD | 3,433,341USD | 4,604,141USD | 2,015,494USD | 8,342,000USD | 7,656,000USD |
| Net Debt | -8,507,628USD | -5,702,589USD | -13,187,000USD | -9,546,306USD | -38,962,838USD | -1,637,499USD | -7,949,000USD | -39,246,000USD |
| Accounts Payable | 544,057USD | 870,229USD | 806,004USD | 1,378,316USD | 2,637,806USD | 155,957USD | 3,507,000USD | 2,849,000USD |
| Property Plant Equipment Net | 0USD | 82,175USD | 173,941USD | 81,313USD | 172,888USD | 1,349USD | 3,818,000USD | 12,233,000USD |
| Property Plant Equipment Gross | 0USD | 82,175USD | 173,941USD | 81,313USD | 172,888USD | 1,349USD | — | — |
| Common Stock Shares Outstanding | 966,124shares | 9,355,710shares | 8,401,047shares | 8,262,119shares | 4,090,599shares | 5,405,963shares | 422,200shares | 389,912shares |
| Non Current Assets Total | 0USD | 720,426USD | 928,669USD | 819,564USD | 189,365USD | 45,794USD | 7,535,000USD | 17,945,000USD |
| Non Current Liabilities Total | 0USD | 0USD | 73,348USD | 1,458,810USD | 72,862USD | 72,862USD | 1,402,999USD | 309,000USD |
| Net Working Capital | 3,151,593USD | 3,224,449USD | 11,221,177USD | 23,810,901USD | 35,783,077USD | -283,495USD | — | — |
| Unclassified Equity | 84,386,344USD | 64,143,780USD | 57,325,632USD | 54,359,694USD | 51,405,295USD | 7,674,547USD | 200,958,000USD | 194,642,000USD |
| Short Term Debt | — | 84,164USD | 101,705USD | 80,494USD | 96,465USD | 96,465USD | 544,000USD | — |
| Short Long Term Debt Total | — | 84,164USD | 175,053USD | 80,494USD | 169,327USD | 169,327USD | 1,343,000USD | — |
| Non Currrent Assets Other | — | 638,251USD | 754,728USD | 738,251USD | 16,477USD | 44,445USD | 3,717,000USD | 5,431,000USD |
| Short Term Investments | — | — | 0USD | 16,806,009USD | 0USD | — | 770,000USD | 1,333,000USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | 96,434USD | — | — | -727,000USD | — |
| Other Assets | — | — | — | 0USD | 0USD | 44,445USD | 46,445USD | — |
| Net Tangible Assets | — | — | — | 24,630,465USD | 35,899,580USD | -238,016USD | 3,210,132USD | — |
| Unclassified Non Current Liabilities | — | — | — | 1,458,810USD | — | — | 1,402,999USD | — |
| Net Receivables | — | — | — | — | 21,056USD | — | 3,486,000USD | 2,031,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 162,897USD |
| Change To Liabilities | -5,543,149USD |
| Change In Working Capital | 368,404USD |
| Operating Cash Flow | -8,937,627USD |
| Net Investments | -4,000,000USD |
| Investing Cash Flow | -4,000,000USD |
| Financing Cash Flow | 11,983,819USD |
| Change In Cash | -953,808USD |
| End Cash Flow | 7,553,820USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,541,070USD | -8,112,450USD | -2,975,117USD | -5,228,919USD | -4,532,430USD | -4,131,047USD | -3,069,036USD | -4,015,267USD |
| Stock Based Compensation | 227,180USD | 785,814USD | 150,614USD | 180,763USD | 240,891USD | 304,122USD | 444,184USD | 782,852USD |
| Other Non Cash Items | 410,154USD | -241,345USD | 55,018USD | 787,703USD | — | 392,255USD | 173,673USD | 437,241USD |
| Change In Working Capital | -5,106,257USD | 4,377,468USD | -134,554USD | 242,264USD | -755,588USD | 431,178USD | 111,824USD | 754,464USD |
| Total Cash From Operating Activities | -7,009,993USD | -3,190,513USD | -3,054,652USD | -4,018,189USD | -5,047,127USD | -3,395,747USD | -2,513,028USD | -2,477,951USD |
| Capital Expenditures | -3USD | 0USD | -3USD | 0USD | 0USD | -3USD | 0USD | -4USD |
| Free Cash Flow | -7,009,990USD | -3,190,513USD | -3,054,650USD | -4,018,189USD | -5,047,127USD | -3,395,747USD | -2,513,028USD | -2,477,951USD |
| Total Cash From Financing Activities | 0USD | 5,872,502USD | 2,722,576USD | 6,284,869USD | 3,151,395USD | 1,801,814USD | 2,591,963USD | 38,064USD |
| Issuance Of Capital Stock | 0USD | 6,000,000USD | 2,339,169USD | 575,069USD | 3,482,650USD | 2,135,001USD | 3,000,002USD | 39,544USD |
| Change In Cash | -7,009,993USD | 2,681,989USD | -332,062USD | 2,266,680USD | -1,895,732USD | -1,593,933USD | 78,935USD | -2,439,887USD |
| Begin Period Cash Flow | 8,507,628USD | 5,825,639USD | 6,157,701USD | 3,891,021USD | 5,786,753USD | 7,380,686USD | 7,301,751USD | 9,741,638USD |
| End Period Cash Flow | 1,497,635USD | 8,507,628USD | 5,825,639USD | 6,157,701USD | 3,891,021USD | 5,786,753USD | 7,380,686USD | 7,301,751USD |
| Depreciation | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Borrowings | — | 0USD | 0USD | — | — | — | 0USD | — |
| Other Cashflows From Financing Activities | — | -530,466USD | 2,235,365USD | -45,497USD | -331,255USD | -333,187USD | -408,039USD | -1,480USD |
| Unclassified Financing Cash Flow | — | — | -1,851,958USD | 5,755,297USD | — | — | — | — |
| Investments | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -20,848,916USD | -15,022,027USD | -15,423,471USD | -14,322,798USD | -7,711,386USD | -3,584,151USD | -47,599,000USD | -43,543,000USD |
| Depreciation | 0USD | 735USD | 1,284USD | 1,781USD | 1,403USD | 852USD | 854,000USD | 859,000USD |
| Stock Based Compensation | 1,358,082USD | 2,305,849USD | 2,965,938USD | 2,957,249USD | 1,510,258USD | 139,960USD | 124,367USD | — |
| Other Non Cash Items | 1,153,421USD | 392,255USD | -430,993USD | -134,157USD | 5,749,720USD | -3,358,236USD | 17,192,000USD | 6,638,000USD |
| Change In Working Capital | 3,514,157USD | 392,255USD | -518,073USD | -1,580,422USD | -5,090,810USD | 118,711USD | 227,000USD | -642,000USD |
| Total Cash From Operating Activities | -14,823,256USD | -12,323,188USD | -13,405,315USD | -13,078,347USD | -11,290,535USD | -3,324,628USD | -29,045,000USD | -39,076,000USD |
| Capital Expenditures | -4USD | 0USD | -5USD | -172,555USD | -3,854USD | -8,208,371USD | -920,999USD | -9,599,000USD |
| Free Cash Flow | -14,823,256USD | -12,323,188USD | -13,405,315USD | -13,250,902USD | -11,294,389USD | -3,324,628USD | -29,966,000USD | -48,675,000USD |
| Net Borrowings | 5,714,800USD | 0USD | — | — | — | 1,163,172USD | 250,000USD | — |
| Total Cash From Financing Activities | 17,544,131USD | 4,747,888USD | 0USD | 363,058USD | 48,337,455USD | 1,163,172USD | 2,368,000USD | 35,059,000USD |
| Issuance Of Capital Stock | 12,396,888USD | 5,510,591USD | 0USD | 0USD | 5,000,000USD | 1,163,172USD | — | — |
| Change In Cash | 2,720,875USD | -7,575,300USD | 3,735,253USD | -29,505,365USD | 37,494,666USD | -2,161,456USD | -29,954,000USD | -14,147,000USD |
| Begin Period Cash Flow | 5,786,753USD | 13,362,053USD | 9,626,800USD | 39,132,165USD | 1,637,499USD | 3,798,955USD | 39,246,000USD | 53,393,000USD |
| End Period Cash Flow | 8,507,628USD | 5,786,753USD | 13,362,053USD | 9,626,800USD | 39,132,165USD | 1,637,499USD | 9,292,000USD | 39,246,000USD |
| Investments | — | 0USD | 22,260,068USD | -16,427,018USD | 447,746USD | -16,599,573USD | -16,599,573USD | — |
| Other Cashflows From Financing Activities | — | -762,703USD | 17,140,568USD | -16,427,018USD | 43,337,455USD | 1,163,172USD | 2,368,000USD | — |
| Total Cashflows From Investing Activities | — | — | 17,140,568USD | -16,427,018USD | 447,746USD | 447,746USD | -3,210,000USD | -9,301,000USD |
| Unclassified Investing Cash Flow | — | — | -5,119,495USD | — | — | 24,804,090USD | 17,175,572USD | — |
| Unclassified Financing Cash Flow | — | — | -17,140,568USD | 16,790,076USD | — | -2,326,344USD | — | — |
| Change To Liabilities | — | — | — | -1,154,829USD | -4,236,656USD | 113,900USD | 376,722USD | — |
| Other Cashflows From Investing Activities | — | — | — | 172,555USD | 451,600USD | 451,600USD | -2,865,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | -5,749,720USD | 3,358,236USD | — | -2,388,000USD |
| Change To Account Receivables | — | — | — | — | — | 3,386,000USD | -747,000USD | -1,861,000USD |
| Change To Inventory | — | — | — | — | — | -3,386,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.